Clinical Trial Certification Requirements Under FDAAA May Be “Time Bomb”

The section of the FDA Amendments Act that requires companies to post information about their clinical trials contains a "hidden time bomb," according to I. Scott Bass, a partner at the law firm Sidley Austin

More from Archive

More from Pink Sheet